Quarterly ResultMay 8, 2026, 06:09 AM
Ocugen Reports Q1 Net Loss of $19.2M; Raises Going Concern Doubt
AI Summary
Ocugen, Inc. reported a net loss of $19.2 million for the first quarter ended March 31, 2026, an increase from $15.4 million in the prior year. The company's operating expenses rose to $19.4 million, up from $16.0 million. Despite raising $34.98 million in net proceeds from equity offerings and warrant exercises, the company's cash of $31.9 million is insufficient to fund operations for the next 12 months, leading to substantial doubt about its ability to continue as a going concern.
Key Highlights
- Q1 2026 net loss was $19.2 million, up from $15.4 million in Q1 2025.
- Operating expenses increased to $19.4 million in Q1 2026 from $16.0 million.
- Net loss per share was $(0.06) for Q1 2026, compared to $(0.05) in Q1 2025.
- Raised $20.7 million net from a common stock offering in January 2026.
- Received $14.2 million net from warrant exercises in March 2026.
- Cash and restricted cash totaled $32.2 million at March 31, 2026.
- Accumulated deficit reached $427.2 million as of March 31, 2026.
- Management expressed substantial doubt about continuing as a going concern.